Search research articles
Contact Us
Filters
Showing results (21-30 of 54) with videos related to
Page
of 6
Sort By:
Cancer
|
August 16, 2001
Randomized phase II study of cyclophosphamide, doxorubicin, and vincristine compared with single-agent carboplatin in patients with poor prognosis small cell lung carcinoma
S C White, P Lorigan, M R Middleton, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
June 5, 2014
Attempted validation of the NUn score and inflammatory markers as predictors of esophageal anastomotic leak and major complications
J M Findlay, R C Tilson, A Harikrishnan, et al.
Cancer Chemotherapy and Pharmacology
|
December 30, 2009
A phase I trial of lomeguatrib and irinotecan in metastatic colorectal cancer
A Sabharwal, P G Corrie, R S Midgley, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
May 20, 2014
The effect of formalizing enhanced recovery after esophagectomy with a protocol
J M Findlay, E Tustian, J Millo, et al.
European Radiology
|
May 8, 2012
Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer
R S Gillies, M R Middleton, C Blesing, et al.
British Journal of Cancer
|
May 14, 2008
A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer
O A Khan, M Ranson, M Michael, et al.
The British Journal of Surgery
|
October 13, 2015
Pragmatic staging of oesophageal cancer using decision theory involving selective endoscopic ultrasonography, PET and laparoscopy
J M Findlay, K M Bradley, E J Maile, et al.
International Journal of Oncology
|
January 6, 2011
Circulating melanoma cells and survival in metastatic melanoma
C Rao, T Bui, M Connelly, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 8, 2017
Circulating tumor DNA predicts survival in patients with resected high-risk stage II/III melanoma
R J Lee, G Gremel, A Marshall, et al.
The British Journal of Surgery
|
January 18, 2017
Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer
J M Findlay, K M Bradley, L M Wang, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 54) with videos related to
Sort By:
Page
of 6
Cancer
|
August 16, 2001
Randomized phase II study of cyclophosphamide, doxorubicin, and vincristine compared with single-agent carboplatin in patients with poor prognosis small cell lung carcinoma
S C White, P Lorigan, M R Middleton, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
June 5, 2014
Attempted validation of the NUn score and inflammatory markers as predictors of esophageal anastomotic leak and major complications
J M Findlay, R C Tilson, A Harikrishnan, et al.
Cancer Chemotherapy and Pharmacology
|
December 30, 2009
A phase I trial of lomeguatrib and irinotecan in metastatic colorectal cancer
A Sabharwal, P G Corrie, R S Midgley, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
May 20, 2014
The effect of formalizing enhanced recovery after esophagectomy with a protocol
J M Findlay, E Tustian, J Millo, et al.
European Radiology
|
May 8, 2012
Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer
R S Gillies, M R Middleton, C Blesing, et al.
British Journal of Cancer
|
May 14, 2008
A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer
O A Khan, M Ranson, M Michael, et al.
The British Journal of Surgery
|
October 13, 2015
Pragmatic staging of oesophageal cancer using decision theory involving selective endoscopic ultrasonography, PET and laparoscopy
J M Findlay, K M Bradley, E J Maile, et al.
International Journal of Oncology
|
January 6, 2011
Circulating melanoma cells and survival in metastatic melanoma
C Rao, T Bui, M Connelly, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 8, 2017
Circulating tumor DNA predicts survival in patients with resected high-risk stage II/III melanoma
R J Lee, G Gremel, A Marshall, et al.
The British Journal of Surgery
|
January 18, 2017
Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer
J M Findlay, K M Bradley, L M Wang, et al.
Page
of 6